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eAppendix. Description of the Intervention  
 
The SELFBACK decision support system 
The following is a condensed description of the SELFBACK system. A more detailed description can be found 
in1, 2:  
• Mork PJ, Bach K, SELFBACK Consortium. A Decision Support System to Enhance Self-Management of 
Low Back Pain: Protocol for the SELFBACK Project. JMIR Res Protoc. Jul 20 2018;7(7):e167. 
doi:10.2196/resprot.9379. 
• Bach K, Szczepanski T, Aamodt A, Gundersen OE, Mork PJ. Case representation and similarity assessment 
in the SELFBACK decision support system. Paper presented at: Case-Based Reasoning Research and 
Development: 24th International Conference, ICCBR 2016; October 31 - November 2, 2016; Atlanta, GA, 
USA. 
  
SELFBACK is an evidence-based decision support system that supports self-management of nonspecific low 
back pain. In specific, SELFBACK provides the user with evidence-based advice on physical activity level, 
strength/ flexibility exercises, and educational content. The self-management advice is delivered via a 
smartphone app and individually tailored to the user’s personal goals, personal characteristics, symptom 
progression and functional level. The SELFBACK system uses the case-based reasoning (CBR) methodology to 
capture and reuse knowledge from successful previous cases to suggest the most suitable self-management plan 
for a current user. Figure 1 illustrates the architecture of the SELFBACK system and the process for producing 
and tailoring the weekly self-management plans (steps 1-5). 
In the current trial, patients with low back pain were referred to the research project from their primary care 
clinician (general practitioner, physiotherapist, chiropractor) or an outpatient spine clinic. The patient was 
screened for eligibility by a research assistant and if eligible, invited to the trial and sent a link to an online web-
based questionnaire (step 1). The questionnaire information was used to create a user profile (step 2), initiate the 
first CBR cycle (i.e., matching of the current case with the most similar and successful previous case in the 
SELFBACK case-base), and produce the first weekly self-management plan. The resulting self-management plan 
is pushed to the mobile phone (step 3) and accessed by the user (step 4). On a weekly basis, the users answered 
a set of tailoring questions in the app (eg, pain intensity, self-efficacy level, fear-avoidance level, barriers to self-
management etc.). In addition, physical activity was tracked by a step detecting wristband (Mi Band 3, Xiaomi) 
connected to the SELFBACK app. The self-reported data and the objective physical activity data for the past 
week was then fed back to the CBR system (step 5) where the refined and enhanced user profile was matched 













Figure 1. Illustration 
of the overall 
architecture of the 
SELFBACK system 
and how the 
modules link 
together to produce 
and tailor the weekly 
self-management 
plans (for more 
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The SELFBACK app 
The following is a condensed description of the SELFBACK app. A more detailed description can be found in3:  
• Sandal LF, Stochkendahl MJ, Svendsen MJ, et al. An App-Delivered Self-Management Program for 
People With Low Back Pain: Protocol for the selfBACK Randomized Controlled Trial. JMIR Res 
Protoc. Dec 3 2019;8(12):e14720. doi:10.2196/14720.  
 
The SELFBACK app presents the self-management advice to the user.  
 
When opening the app, the user is taken to the plan screen (Figure 2), which displays an overview of the daily 
self-management activities that can be performed by the users.  
 
The top bar shows a timeline for the current week. Users can scroll 
flip through the days and review the activities completed on 
previous days and the recommended activities for the coming days. 
By selecting a previous date, the user can see a previous plan. 
 
The current day is marked by the red circle.  
The small red dots below the dates indicate number of activities 
completed. If all three components are completed within one day, a 
yellow star is displayed. The red bar below the dates indicate the 
duration of the current self-management plan (in this case, a new 
plan was created on Tuesday 7th August).  
 
The three main components (ie. steps/physical activity, exercise, 
and education) are represented by separate ribbons and icons. The 
grey/red circle surrounding the icon shows the completion status 
for the activities. In this case, 994 steps of the goal of 3,300 step 
has been completed.  
 
The ribbon at the bottom of the screen is a menu to navigate 
through different parts of the app and content.  
 
The toolbox includes a library of educational messages 
read and exercises performed, tools (ie. goal setting, 
mindfulness audio), and educational items, such as 
‘about low back pain’, etc. 
 
Overall statistics for all three components (eg. total 
number of steps, total number of educational items 
read etc.)  
 
Settings where the users can adjust the app interaction 
(eg. turn notifications on/off).  
Figure 2. Screenshot of the plan 
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From the plan screen, each of the three content ribbons can be clicked to enter a new subscreen.  
 
Exercise 
In the exercise screen an overview of exercises suggested in the current self-management plan is displayed 
(Figure 3).  
 
All exercises are displayed with a small picture and a descriptive 
title.  
 
By clicking the individual exercise, the user is shown a new 
screen including a video of the exercise as it should be performed 
and a detailed description of the exercise performance.  
 
When a user has performed the exercise, they are taken to a 
reporting screen where they can enter the number of performed 
repetitions and sets.  
 
Once an exercise is completed, it is “greyed out” in the overview 
(however, it can always be accessed at a later stage).  
 
The user can choose to skip an exercise or replace an exercise 
with another exercise. If the user uses this option, s/he is asked to 
report the reason by choosing between the following response 













Figure 3. Screenshot of the 
exercise screen from the 
SELFBACK app.  
  
© 2021 Sandal LF et al. JAMA Internal Medicine. 
Educational messages 
When clicking the education ribbon in the plan screen, users are taken to new screen with an educational 
message showing a short informative title and a short message with a length of approximately 140 characters 
(Figure 4).  
 
The short message may be displayed as a quiz, with response 
options “yes” or “no”. After the user indicates the response, s/he 
is taken to a new screen showing the correct answer and an 
explanation. 
 
Some of the short messages are supplemented by a “read more” 
option, in which a longer message (≥500 characters) would 
appear below the short message.  
 
The short messages can also be accompanied by links to tools 
within the app or longer reads placed in the general information 
section in the tools section.  
 
The educational content is tailored to the individual user 
according to the answers on the baseline and follow-up 















Figure 4. Screenshot of an 
educational screen from the 
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Physical activity 
When clicking the physical activity ribbon in the plan screen, users are taken to a new screen providing statistics 
related to their level of physical activity (Figure 5).  
 
The number of steps is displayed, and the user can choose 
between a daily, weekly, or monthly overview.  
The bottom part of the screen shows different statistics for the 
chosen timeframe.  
 
 
The statistics include:  
 
Percentage completion of the set goal for the day, average for the 
week or month.  
 
Number of total steps for the day, week, or month.  
 
An estimation of energy expenditure. 
 
An estimation of the distance walked in kilometers for the day, 














Figure 5. Screenshot of the 
physical activity screen from the 
SELFBACK app.  
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The content of the intervention 
 
The development of the intervention and its related content followed a systematic six step process of 
Intervention Mapping outlined by Bartholomew et al.4. Through this process a logic model of the problem was 
outlined, followed by a formulation of program outcomes and objectives into a logic model of change to inform 
the program design and program production. The process is informed by literature and is evidence-based in its 
approach.  
 
The content of the intervention was based on current treatment guidelines for low back pain, evidence-based 
treatment components and underpinned by theories for behavior change and engagement in digital health 
interventions.  
 
The exercise content consisted of a bank of 70 exercises organized in 6 targets: 1) flexibility exercises, 2) pain 
relieving exercises in addition to strength exercises for 3) back extensors, 4) gluteal and hip muscles, 5) 
abdominal muscles, and 6) core muscles.  
 
It is important to note that the individual user could adjust their time available for exercise in the tailoring 
session and consequently, the exercise dose performed would differ in both content, volume and intensity across 
the intervention group.  
 
The educational content was organized in 14 overarching main themes with up to nine subthemes nested within 
them. Examples of main themes were “general information about low back pain”, “how to overcome barriers for 
self-management of low back pain”, “how to set SMART goals” and “low back pain and other medical 
conditions”.  
 
The physical activity screen showed continuous feedback on the number of steps and information on the 
completion level of the set goal.  
 
The daily goal for number of steps was suggested by the SELFBACK system and thereafter adjusted by the 
individual user in the weekly tailoring session. The range for the step goal could range between 3,000 and 
10,000 steps/day. The suggested daily step goal was calculated as a mean between the past week’s set goal and 
the actual performance in the past week. If the suggested step goal was lower than 6,000 steps/day, the user 
could adjust this within a ±10% range. If the suggested step goal was between 6,000 and 8,000 steps/day, the 
users could adjust this within a ±15% range. If the suggested step goal was higher than 8,000 steps/day, the 
users could adjust this within a ±20% range. 
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eTable 1. Means (SD) and Adjusted Between-Group Differences for Primary Outcome at 3 and 9 Months for All Sensitivity 
Analyses  
 
 Mean (SD)a  
 Usual Care 
(n = 229) 
SELFBACKb  
(n = 232) 
Between-Group Differences.  
Adjustedc Mean (95% CI) 
Roland-Morris Disability Questionnaire    
Sensitivity analyses    
Multiple imputation analysesd, (n = 461)    
  Baseline  10.4 (4.4)  
  3 months 7.4 (5.4) 6.6 (4.7) -0.73 (-1.45 to -0.01) 
  9 months 6.7 (5.6) 5.9 (5.3) -0.78 (-1.54 to -0.03) 
Complete case analyses, (n = 290)    
  Baseline  9.9 (4.2)  
  3 months 7.1 (5.3) 6.4 (4.6) -0.64 (-1.47 to 0.18) 
  9 months 6.7 (5.4) 5.7 (5.1) -0.97 (-1.80 to -0.14) 
Per protocol analysese, (n = 410)    
  Baseline  10.4 (4.4)  
  3 months 7.4 (5.4) 6.9 (4.8) -0.61 (-1.36 to 0.14) 
  9 months 6.8 (5.6) 6.2 (5.0) -0.75 (-1.54 to 0.04) 
Abbreviations: SD, Standard Deviation; CI, Confidence Interval 
a Marginal means from a crude linear mixed model and SDs from raw data among persons with information at the specific time points  
b App-delivered self-management support in addition to usual care 
c Adjusted for stratification variables (country and clinician), education ((<10, 10-12, >12 years), pain duration (<1, 1-4, 5-12, >12 weeks), average pain intensity past week at baseline (continuous, 
range 0-10), sex (male, female), age (years) 
d Roland Morris Disability Questionnaire scores were imputed using a multivariate normal model with 20 imputations 
e Adherence to the protocol was defined as creating at least 6 weekly self-management plans during the first 12 weeks post randomization for the intervention group  
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eTable 2. Proportion of Participants Improved and Relative Risk Comparing Groups at 3 and 9 Months  
 
 Usual care SELFBACKa  

















Ratioc (95% CI) 
Improvement ≥2 points on RMDQ      
  Baseline 0/229 0 N/A 0/232 N/A N/A  
  3 months 114/190 60.0 0.98 (0.70 to 1.37) 143/209 68.4 1.41 (0.91 to 2.20) 1.44 (0.94 to 2.22) 
  9 months 115/182 63.0 1.13 (0.80 to 1.60) 112/170 65.0 1.25 (0.80 to 1.97) 1.11 (0.71 to 1.73) 
Abbreviations: CI, Confidence Interval; RMDQ, Roland-Morris Disability Questionnaire; N/A, Not Applicable 
a App-delivered self-management support in addition to usual care  
b Adjusted for stratification variables (country and clinician), education (<10, 10-12, >12 years), pain duration (<1, 1-4, 5-12, >12 weeks), average pain intensity past week at baseline (continuous, 
range 0-10), sex (male, female), age (years) 
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eTable 3. Odds Ratio for Secondary Binary Outcomes Comparing Groups at 3 and 9 Months  
 Usual care SELFBACKa  
 No. Improved/ 
No. Total 
Adjustedb  










Odds Ratiod (95% CI) 
Pain Self-Efficacy Questionnaire, >40      
  Baseline, both groups 302/460 1.00 (reference) - -  
  3 months 133/188 1.39 (1.00 to 1.94) 173/205 2.82 (1.94 to 4.10) 2.02 (1.27 to 3.23) 
  9 months 140/181 1.88 (1.32 to 2.67) 143/169 2.53 (1.81 to 3.53) 1.35 (0.85 to 2.14) 
Fear-Avoidance Belief Questionnaire, >50 perc. (>10)     
  Baseline, both groups 221/460 1.00 (reference) - -  
  3 months 69/188 0.63 (0.46 to 0.85) 79/205 0.73 (0.54 to 0.98) 1.16 (0.79 to 1.72) 
  9 months 61/181 0.56 (0.40 to 0.77) 47/169 0.46 (0.34 to 0.63) 0.82 (0.54 to 1.26) 
Average Pain Intensity Past Week, >5      
  Baseline, both groups 185/461 1.00 (reference) - -  
  3 months 53/189 0.57 (0.42 to 0.78) 34/205 0.31 (0.21 to 0.45) 0.53 (0.34 to 0.84) 
  9 months 50/181 0.55 (0.40 to 0.77) 29/169 0.33 (0.23 to 0.48) 0.60 (0.38 to 0.95) 
Worst Pain Intensity Past Week, >5      
  Baseline, both groups 338/461 1.00 (reference) - -  
  3 months 94/189 0.35 (0.26 to 0.48) 72/205 0.16 (0.12 to 0.23) 0.47 (0.31 to 0.70) 
  9 months 85/181 0.32 (0.22 to 0.44) 57/169 0.16 (0.11 to 0.23) 0.50 (0.32 to 0.76) 
Brief Illness Perception Questionnaire, >75 perc. (>52)     
  Baseline, both groups 100/461 1.00 (reference) - -  
  3 months 36/187 0.79 (0.54 to 1.16) 21/205 0.37 (0.23 to 0.60) 0.47 (0.27 to 0.84) 
  9 months 26/181 0.50 (0.32 to 0.79) 16/169 0.39 (0.23 to 0.66) 0.77 (0.40 to 1.50) 
Saltin-Grimby Physical Activity Level, moderate/vigorous    
  Baseline, both groups 338/461 1.00 (reference) - -  
  3 months 94/189 0.99 (0.75 to 1.29) 72/205 0.85 (0.65 to 1.10) 0.86 (0.60 to 1.23) 
  9 months 85/181 0.95 (0.70 to 1.31) 57/169 1.12 (0.83 to 1.50) 1.17 (0.79 to 1.75) 
Global Perceived Effect, improvede     
  Baseline, both groups 0/461  - -  
  3 months 99/187 1.44 (1.04 to 1.98) 149/205 3.42 (2.15 to 5.44) 2.38 (1.53 to 3.69) 
  9 months 91/181 1.22 (0.85 to 1.77) 129/168 4.17 (2.57 to 6.77) 3.41 (2.14 to 5.42) 
Abbreviations: CI, Confidence Interval  
a App-delivered self-management support in addition to usual care  
b Adjusted for stratification variables (country and clinician), education (<10, 10-12, >12 years), pain duration (<1, 1-4, 5-12, >12 weeks), average pain intensity past week at baseline (continuous, 
range 0-10), sex (male, female), age (years) 
c Baseline for both groups as reference group 
d Usual care as reference group 
e Usual care at 6 weeks as reference group  
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eTable 4. Mean (SD) and Between-Group Differences for Exploratory Outcomes at 3 and 9 Months 
 
 Mean (SD)a  
 
 
Usual Care   
(n = 229) 
SELFBACKb  
(n = 232) 
Between-Group Differences,  
Adjustedc Mean (95% CI) 
Work ability (0-10)    
  Baseline  6.7 (2.0)  
  3 months 7.1 (2.1) 7.4 (1.8) 0.24 (-0.13 to 0.61) 
  9 months 7.3 (2.0) 7.5 (1.9) 0.23 (-0.16 to 0.62) 
Perceived Stress Scale (0-40)     
  Baseline  14.9 (6.8)  
  3 months 14.8 (7.2) 13.9 (7.1) -0.78 (-1.74 to .018) 
  9 months 13.8 (7.1) 12.3 (7.1) -1.31 (-2.31 to -0.31) 
Patient Health Questionnaire-8 (0-24)    
  Baseline  6.4 (4.3)  
  3 months 6.2 (4.6) 5.8 (4.5) -0.43 (-1.05 to 0.18) 
  9 months 5.8 (4.9) 5.1 (4.3) -0.71 (-1.35 to -0.07) 
Abbreviations: SD, Standard Deviation; CI, Confidence Interval 
a Marginal means from a crude linear mixed model and SDs from raw data among persons with information at the specific time points  
b App-delivered self-management support in addition to usual care 
c Adjusted for stratification variables (country and clinician), education (<10, 10-12, >12 years), pain duration (<1, 1-4, 5-12, >12 weeks), average pain intensity past week at baseline 
(continuous, range 0-10), sex (male, female), age (years)  
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eTable 5. Odds Ratio for Exploratory Binary Outcomes Comparing Groups at 3 and 9 Months 
 
 Usual care SELFBACKa  
 No. Improved/ 
No. Total 
Adjustedb  





Odds Ratioc  
(95% CI) 
Between-Group  
Differences. Adjustedb  
Odds Ratiod (95% CI) 
Pain Medication, ≥1 day/week      
  Baseline, both groupsc 367/461 1.00 (reference) - -  
  3 months 159/189 1.49 (1.03 to 2.15) 186/205 2.65 (1.67 to 4.20) 1.78 (1.00 to 3.14) 
  9 months 159/181 2.17 (1.41 to 3.33) 150/169 2.03 (1.27 to 3.23) 0.93 (0.50 to 1.73) 
Work Ability, high (>7)      
  Baseline, both groupsc 132/345 1.00 (reference) - -  
  3 months 75/145 1.79 (1.30 to 2.46) 83/149 2.21 (1.51 to 3.23) 1.24 (0.79 to 1.95) 
  9 months 77/137 1.90 (1.31 to 2.77) 77/122 2.91 (1.89 to 2.48) 1.53 (0.91 to 2.57) 
Sleep Problems, insomnia      
  Baseline, both groupsc 326/461 1.00 (reference) - -  
  3 months 124/187 0.79 (0.59 to 1.06) 127/205 0.65 (0.47 to 0.89) 0.82 (0.55 to 1.21) 
  9 months 111/181 0.65 (.048 to 0.89) 98/169 0.55 (0.39 to 0.76) 0.84 (0.56 to 1.26) 
Perceived Stress Scale, high (>27)     
  Baseline, both groupsc 12/461 1.00 (reference) - -  
  3 months 9/187 2.49 (1.22 to 5.05) 9/205 1.67 (0.69 to 4.02) 0.67 (0.26 to 1.72) 
  9 months 2/181 0.68 (0.24 to 1.94) 3/168 0.64 (0.13 to 3.19) 0.94 (0.16 to 5.58) 
Perceived Health Questionaire-8, moderate/severe (>15)    
  Baseline, both groupsc 20/461 1.00 (reference) - -  
  3 months 8/187 0.99 (0.54 to 1.81) 9/205 1.05 (0.48 to 2.31) 1.06 (0.42 to 2.67) 
  9 months 9/181 1.31 (0.65 to 2.66) 6/168 0.99 (0.48 to 2.07) 0.76 (0.30 to 1.93) 
Patient Acceptable Symptom State, acceptablee     
  Baseline, both groups N/A  N/A   
  3 months 87/187 1.21 (0.88 to 1.67) 124/205 2.09 (1.36 to 3.21) 1.72 (1.13 to 2.62) 
  9 months 98/181 1.64 (1.19 to 2.27) 109/168 2.47 (1.59 to 3.82) 1.50 (0.98 to 2.31) 
Abbreviations: CI, Confidence Interval 
a App-delivered self-management support in addition to usual care  
b Adjusted for stratification variables (country and clinician), education (<10, 10-12, >12 years), pain duration (<1, 1-4, 5-12, >12 weeks), average pain intensity past week at baseline (continuous, 
range 0-10), sex (male, female), age (years) 
c Baseline for both groups as reference group 
d Usual care as reference group 






Effectiveness of a tailored app-delivered self-management program for 
reducing pain-related disability in people with low back pain: statistical 
analyses plan (SAP) for the SELFBACK randomised controlled trial. 
 
Section 1: Administrative Information 
 
SAP Version 0.2 (March 17th, 2020) 
 
This SAP is based on the protocol registered in ClinicalTrials.gov (NCT03798288) and the 
published protocol paper: Sandal et al. (2020). Effectiveness of an App-Delivered Self-
Management Program for People with Low Back Pain - a Protocol for the selfBACK 
Randomised Controlled Trial, JMIR Research Protocols1. The structure and content of the 
SAP is adopted from the Guidelines for the Content of Statistical Analyses Plans in Clinical 
Trials2. 
 
Table 1. SAP revision history 
Revision  Justification for revision Version (date) 
   
   
 
This SAP is developed as a collaborative effort between all partners in the SELFBACK 





       
                                               
________________                _____________________                 __________________ 









Section 2: Introduction 
 
2.1 Background and rational 
 
Low back pain (LBP) is a major contributor to years lived with pain and disability, and the 
societal costs related to healthcare, social benefits, sickness absence, and reduced work 
ability are high. Clinical guidelines recommend patient education, exercise therapy, 
multidisciplinary treatments and combined physical and psychological interventions to 
manage LBP, and self-management programmes that include these elements have been 
suggested as a promising option. Digital solutions, such as mobile applications (apps), have 
been suggested as platforms for supporting self-management of chronic conditions, but 
evidence of their quality and effectiveness is limited. The SELFBACK project aims to fill this 
knowledge gap by developing an evidence-based and data-driven decision support system 
(DSS) delivered via a smartphone app to facilitate, improve and reinforce self-management 
of non-specific LBP3. The DSS suggests self-management plans consisting of physical 
activity advice, patient education and recommendations for physical exercise tailored to the 
individual’s specific health information. The effectiveness of the SELFBACK DSS will be 




The objective is to evaluate the effectiveness of the SELFBACK DSS in addition to usual care 
versus usual care only in a RCT. Primary outcome is pain-related disability at three months 
measured by the Roland-Morris Disability Questionnaire (RMDQ). We hypothesise that 
participants randomised to using the SELFBACK app in addition to usual care will have at 
least two points difference in RMDQ at three months, compared to participants receiving 
usual care only. 
The effect of the intervention on secondary outcomes, including quality of life, use of 
non-prescriptive medication, sleep problems, depressive symptoms, stress, functional ability 
and LBP intensity, will be assessed at three months. We will also evaluate the effect on these 
measures, as well as on RMDQ, at nine months. 
 
Section 3: Study Methods 
 
3.1 Trial design 
 
The SELFBACK study is designed as an international multi-centre RCT where patients with 
non-specific LBP are randomised to two parallel groups (allocation ratio 1:1). The 
intervention group will be given access to the SELFBACK DSS, delivered via a smartphone 
app (SELFBACK app) in addition to usual care, whereas the control group will get usual care 
only. In addition, participants in the intervention group are given a wearable device (i.e., a 
step-detecting wristband) that interacts with the app. The target population are people seeking 
care for non-specific LBP from a primary care provider (general practitioner, physiotherapist, 
chiropractor) or an out-patient clinic (the Spine Centre of Southern Denmark); see also 
sections 5.2 and 5.3. 
The SELFBACK system is a data-driven predictive DSS that uses case-based reasoning 
(CBR) methodology to capture and reuse participant cases in order to suggest the most 
suitable self-management plan for participants. Based on the step count and participant’s self-




educational messages, physical activity advice and exercise recommendations matched to the 
participant’s health status. The self-management plans are updated weekly based on the 




Randomisation is performed as a block randomisation with permuted blocks of random size 
unknown to the research team and stratified by country (Denmark or Norway) and care 
provider (general practitioner, physiotherapist, chiropractor, or Spine Centre). Randomisation 
is performed by a web-based randomisation system (Web Case Report Form; WebCRF) 
developed and administered by Unit of Applied Clinical Research, Faculty of Medicine and 
Health Sciences, NTNU, Trondheim, Norway. This unit is not otherwise involved in the trial 
management or trial conduct. 
 
3.3 Sample size 
 
The sample size calculations are described in detail in the registered protocol. Briefly, the 
study aims to detect a two-point difference in pain related disability measured by the RMDQ 
at three months follow-up. Based on calculations and simulations, and assuming 30% drop-




The SELFBACK study is designed as a superiority RCT assessing the effectiveness of the 
SELFBACK DSS in addition to usual care (intervention group) compared to usual care only 
(control group) for people with non-specific LBP. 
 
3.5 Interim analyses and stopping guidance 
 
As serious adverse events are unexpected, no interim analysis or a priori defined stopping 
rules are defined or implemented for this trial. 
 
3.6 Timing of outcome assessment 
 
The primary and secondary outcome variables will be assessed at baseline and at six weeks, 
three months, six months and nine months follow-up. This allows analyses of repeated 
measures on both primary and secondary outcomes, and thus increased statistical power 
compared to outcomes assessed at a single time-point. The main outcome of the study is pain 
related disability measured by RMDQ at three months follow-up.  
 
3.7 Timing of final analyses 
 
The analyses of the primary outcome will be conducted within six months after the last 
participant has completed the three months follow-up questionnaire. The inclusion of 
participants will last until December 2019, and thus the final analyses should be ready by end 
of September 2020. Analyses of secondary outcomes assessed at three months will be 
analysed subsequently to the primary outcome and conducted within the same time frame. 
The effect on outcomes assessed at nine months follow-up will be analysed after the final 




partners involved in each sub-project. A data steering committee comprising one member 
from each participating partner will manage the use of the data.  
 
Section 4: Statistical Principles 
 
4.1 Confidence intervals and P-values 
 
As recently recommended in the medical literature, we will not use a specific P-value 
threshold to decide upon statistical significance as this often leads to misinterpretation of 
results. For the same reasons, we will not adjust for multiple comparisons since this build 
upon a strict use of a certain P-value threshold. Instead, the precision of the estimated effects 
of the intervention will be assessed by a 95% confidence interval, and the effect will be 
described as a point estimate (mean difference or odds ratio) with accompanying confidence 
limits. Whenever P-values are reported, we will do so by presenting their actual value, and 
not reduce them to a binary inequality under or above a threshold value.  
 
4.2 Adherence and protocol deviations 
 
Since the intervention focuses on the participant’s use and interaction with the SELFBACK 
DSS in the app, and since this interaction constitutes the basis for a self-management plan 
that is updated weekly, we will define adherence to the intervention as receiving an updated 
self-management plan for six of the first 12 weeks after enrolment. We will present numbers 
and the proportion within the intervention group adhering to the intervention and this will 
provide the basis for per protocol analyses. In sensitivity analyses we will also explore the 
influence of defining adherence differently to better capture cases who improve rapidly and 
do not need self-management support towards the end of the three months follow-up period, 
e.g. using four of the first six generated plans as criteria for adherence. Similarly, we will 
conduct sensitivity analyses where we aim at capturing more continuous use of the app 
throughout the follow up period; e.g. at least two plans generated during each four-week 
follow-up period.  
Protocol deviations may occur due to technical failures at either the front end (i.e., 
app, smart phone or the wearable device) or the back end (server down-time) that causes 
users to be unable to interact with the DSS or not having a weekly plan generated. The 
number of protocol deviations, their reasons, and how many participants were affected will 
be summarised. Moreover, since some participants may answer the follow-up questionnaires 
at a somewhat later time point than the intended six weeks, three, six and nine months, we 
will report the variation in follow-up time for each period. 
 
4.3 Analysis populations 
 
The main effect of the intervention will be analysed according to the intention-to-treat 
principle using linear mixed models for continuous outcomes and generalized estimated 
equations (GEE) for binary outcomes, and the analyses will include all participants initially 
enrolled in the study and who answered the baseline questionnaire and were randomised. The 
web-based baseline questionnaire does not allow participants to proceed without filling in an 
answer, so there will be no missing data at this time point. A similar solution will be used for 
the follow-up questionnaires, but missing data will be generated if participants do not answer 




Any missing values throughout the follow-up period are inherently accounted for in 
the mixed model approach, but multiple imputation methods and complete case analysis will 
be applied in sensitivity analyses (see chapter 6.2 and 6.3 below for further details). A 
complete case will be defined as a participant who has answered both the baseline and the 
three-month questionnaire. We will also conduct per protocol analyses only including 
participants from the intervention arm who are defined as adhering to the intervention (i.e., 
having an updated self-management plan created during six of the 12 first weeks, see chapter 
4.2 for more details).  
 
Section 5: Trial Population 
 
5.1 Screening data 
 





Detailed inclusion and exclusion criteria are described in the registered protocol. Briefly, the 
participant must be ≥18 years and seek care from primary health-care practice or a specialised 
outpatient hospital facility (Spine Centre, see details below) for non-specific LBP within the 
past 8 weeks. They must also report mild-to severe pain-related disability (≥6 on RMDQ) and 




The recruitment of participants is conducted in Trondheim, Norway and Odense, Denmark. 
In both Norway and Denmark, participants are recruited from general practice, physiotherapy 
and chiropractic clinics. In Denmark, participants are also recruited from the Spine Centre of 
Southern Denmark. The recruitment started in March 2019 and will continue until December 
2019. A total of 350 participants are to be recruited to the RCT; 75% (n=262) in Denmark 
and 25% in Norway (n=88). Further details on recruitment are given in the registered 
protocol.  
 
5.4 Withdrawal and follow-up 
 
Each participant is informed that they can withdraw from the study at any time, and that they 
then have the right to have any personal, health and questionnaire data deleted. If a 
participant withdraws during the follow-up period, but do not require already collected data 
to be deleted, the data will be used in the analyses until the time point for withdrawal. For 
analyses of the primary and secondary outcomes at three months, loss to follow-up is defined 
as not answering the three-month questionnaire. Loss-to-follow-up will be assessed for each 
outcome variable separately. For secondary outcomes measured at later follow-up points, loss 
to follow-up is defined according to the time-point when the last information is collected for 
that particular outcome. Number of participants providing information at each follow-up time 
point will be visualised in the CONSORT flow-chart, and this also displays the number who 






5.5. Baseline patient characteristics 
  
Eligible participants fill in a baseline web questionnaire after verbally consenting to take part 
in the study. Baseline characteristics that are collected include: age, sex, height, weight, 
housing (live alone or with family), ethnicity, education, employment, work characteristics, 
physical activity, sleep problems, mental health, stress, quality of life, and various pain-
related factors (e.g., localisation, duration, intensity, coping, disability and limitations, 
perceptions and beliefs). Depending on the nature of the variables, we will summarise this 
information in a baseline table showing mean values with standard deviation or numbers and 
percentages within the two trial arms (intervention and control). We will not conduct any 
statistical tests of baseline differences, as this violates the assumptions for the randomisation 
procedure.  
 
Section 6: Analyses 
 
6.1 Outcome definitions 
 
All outcome variables described below are assessed at baseline, six weeks, three, six and nine 
months. The primary follow-up time point is three months, both for the primary and 
secondary outcome variables described below. In later analyses we will also assess more 
long-term effects using nine months as the follow-up time point. For each follow-up period, 
all previous measures will inform the repeated measures analyses (e.g. baseline and six-week 
data will be included when analysing effects at three months, and all previous time points will 
be included in repeated measures analyses of more long-term effects at nine months).  
   
Primary outcome variable 
 
The primary outcome is pain-related disability assessed at three months, measured by the 
RMDQ4. The questionnaire includes 24 items asking participants to indicate if they 
experience functional impairments by answering “yes” or “no” to a series of descriptions of 
functional abilities. The RMDQ score ranges from 0 to 24, where a higher score indicates 
higher levels of disability due to LBP. The main analyses will be based on the raw scores, 
and we will estimate mean group differences in RMDQ at three months using a linear mixed 
model for repeated measures. We will also construct a binary variable representing a 
clinically meaningful change in RMDQ of two points or more during the three months 
follow-up period that will be analysed using a logistic GEE analyses for repeated measures to 
estimate odds ratios between the groups. Since the size of a clinically meaningful change in 
RMDQ has been debated, we will also construct a binary variable representing a larger cut-
off (e.g. 4 points change). For more details on these analyses, see chapter 6.2 below.  
 
Secondary outcome variables  
 
 LBP intensity within the past week will be assessed by asking “Please indicate your 
average/worst low back pain level during the last week“, using an 11-point numerical 
rating scale (NRS) ranging from “0 (zero)” to “10”5. We will compare mean group 
differences in LBP intensity using linear mixed models. We will also construct a 
binary variable to indicate moderate/severe pain (>5 points) that will be analysed 




 Pain medication is informed by the question “How many days during the last week 
have you taken non-prescription pain medication for low back pain?” with four 
response options ranging from “never” to “daily”. The variable will be analysed both 
as an ordinal variable of the original scale and a binary variable classified as Never vs 
≥1 time using logistic GEE analyses. 
 The Fear-Avoidance Belief Questionnaire (FABQ) assesses participant’s beliefs about 
how physical activity and work affect their LBP6. The FABQ is a 5-item 
questionnaire, where the participants score their beliefs about their LBP on an ordinal 
scale ranging from “zero [completely disagree]” to “six [completely agree]”. The four 
latter questions will be summed (range 0-24) to represent fear avoidance beliefs about 
physical activity and analysed as a continuous variable to compare mean group 
differences using linear mixed models. We will also classify people as having high or 
low fear for physical activity to examine possible differences in a binary variable 
using logistic GEE analyses. The classification cut-off will be obtained from the 
distribution of the variable (e.g. median value).  
 The Pain Self-Efficacy Questionnaire (PSEQ) assesses the participant’s level of 
confidence in carrying out specific activities despite their pain7. The PSEQ is a 10-
item questionnaire scored on an ordinal scale ranging from “zero [completely 
disagree]” to “six [completely agree]”. A total score is calculated by summing the 
scores for each of the 10 items, yielding a maximum total score of 60, where higher 
scores reflect stronger self-efficacy beliefs.  We will compare mean group differences 
in PSEQ using linear mixed models. We will also construct a binary variable to 
indicate low (<20) and high (<40) self-efficacy that will be analysed using logistic 
GEE . 
 Activity Limitation due to LBP is measured by “Has low back trouble caused you to 
reduce your activity during the last 12 months? with response options “yes” and “no” 
to each of the domains work or leisure. The two variables will be analysed using 
logistic GEE to estimate odds ratios between the groups. A variable combining 
information from the two domains (i.e. activity limitations in both work and leisure) 
will also be constructed and analysed as a binary variable using logistic GEE. 
 Work ability is measured by a single-item on current work ability rated on an 11-point 
NRS scale ranging from “zero [completely unable to work]” to “10 [work ability at its 
best]”8. We will compare mean difference in work ability using linear mixed models. 
We will also classify people into a binary variable representing high (>7 points) vs 
low work ability and analyse this using logistic GEE.  
 Self-reported physical activity is evaluated by the Modernised Saltin-Grimby Physical 
Activity Level Scale, where participants indicate their amount of time per week 
performing leisure activities with four levels of intensity ranging from sedentary to 
vigorous physically active9. The resulting four categories will be analysed as an 
ordinal variable in logistic GEE, as well as collapsed into a binary variable indicating 
no/light activity vs moderate/vigorous activity.  
 Function is evaluated by the Patient Specific Functional Scale (PSFS) where 
participants are asked to rate up to two self-selected activities they are unable to do or 
are having difficulties performing10. The ability to carry out the activity/activities is 
rated from “zero [unable to perform]” to “10 [fully able to perform]”. We will 
compare mean difference in function using linear mixed models, and also analyse a 
binary variable representing a clinically important improvement (≥3 points) in 
function for each of the two items using logistic GEE. 
 Sleep problems is assessed by four items including problems with falling asleep, 




Response options for each item are “seldom or never”, “sometimes” or “several times 
a week”. The information retrieved from these four items approximates the 
information necessary to diagnose insomnia according to the DSM-V criteria. The 
resulting binary variable (insomnia vs no insomnia) will be analysed using logistic 
GEE to estimate odds ratios for insomnia between the groups.  
 Stress is evaluated with the Perceived Stress Scale (PSS), a 10-item questionnaire 
asking about frequency of thoughts and feelings related to perceived stress12. 
Participants indicate their frequency of experiencing stress-related issues on a 5-point 
Likert scale, ranging from “0 [never]” to “4 [very often]”. Positive score items are 
reversed and then all items are summed to a score ranging from 0 to 40. The resulting 
sum score will be analysed as a continuous variable to estimate mean differences in 
stress using linear mixed models. Cut-offs at 14 and 27 to indicate low, moderate and 
high stress will be used to construct a binary variable for analyses using logistic GEE.  
 Health-related quality of life is evaluated with the EuroQoL 5-dimension (EQ-5D) 
questionnaire13. A 5-point Likert scale ranging from “1 [no problems]” to “5 
[complete inability]” is used to assess the health-related quality of life within each of 
the five dimensions (i.e., mobility, self-care, activities, pain/discomfort and 
anxiety/depression). The five dimensions will be analysed separately as ordinal 
variables using logistic GEE. We will also construct an overall index based on value 
sets from Denmark and Norway that combines all items and then estimate the mean 
difference between groups using linear mixed models. 
 General health is assessed on a 100 point vertical scale where 0 indicates the worst 
health you can imagine and 100 the best imaginable health13. The variable will be 
analysed as a continuous variable estimating the mean difference between groups 
using linear mixed models.  
 The Brief Illness Perception Questionnaire (BIPQ) evaluates the participants’ illness 
perception in an 8-item questionnaire14. Items are scored on an ordinal scale ranging 
from “0 [no problems]” to “10 [worst severity]”. Adding the separate score values 
creates a summary score with a higher score indicating more threatening view of the 
pain. The summed score will be analysed as a continuous variable to compare mean 
group differences, and we will also construct a binary variable with cut-offs indicated 
from the distribution of the variable (e.g. percentiles) since no clinical cut offs are 
suggested in the literature. 
 The Patient Health Questionnaire-8 (PHQ-8) is an 8-item questionnaire used to 
evaluate the participants’ depressive symptoms15. Items are reported on a 4-point 
Likert scale scoring frequency of experiencing symptoms of depression. The nine 
items will be summed and analysed both as a continuous variable using linear mixed 
models and as a categorical variable using cut-offs of 5, 10, 15 and 20 to classify 
people into none, mild, moderate, moderately severe, and severe categories using 
logistic GEE for ordinal and binary (±15) variables.  
 Patient Acceptable Symptom State asks “Considering your low back pain, do you 
consider your current state satisfactory?” with response options yes or no16. This will 
be analysed as a binary variable using logistic GEE. 
 Patient’s Global Perceived Effect is a single item question where participants are 
asked to rate improvement or deterioration of their LBP compared to before the 
intervention with seven response options ranging from -5 [markedly worse] to 5 
[markedly better]17. The variable will be analysed as an ordinal variable using logistic 
GEE, and also collapsed into a binary variable indicating improved vs not improved.  
 Current pain duration is measured by the question “What is the length of time you 




“less than 1 week” to “more than 12 weeks”. Although this information is collected at 
follow-up, the variable will not be included as a secondary outcome due to possible 
confusion about pain episode and the time frame for the episode.  
 Long term pain duration is measured by “What is the total length of time that you 
have had low back trouble during the last 12 months?” with five response options 
ranging from “0 days” to “every day”. Similar to the above, although this information 
is collected at follow-up the variable will not be included as a secondary outcome due 
to possible overlapping time frame with baseline and follow-up time points. 
 
 
6.2 Analyses methods 
 
The primary analysis will estimate mean difference and 95% confidence interval (CI) in 
RMDQ score at three months follow-up between the intervention and control group (i.e., 
SELFBACK in addition to usual care versus usual care only). The analyses will be conducted 
according to the intention-to-treat principle using a linear mixed model for repeated 
measures. This model includes all available data for all participants at each time point (i.e. 
baseline, six weeks, and three months). The distribution of the RMDQ score will be assessed, 
and the variable may be transformed (e.g. log transformation) to better fit with the 
assumptions for the regression analyses. In the regression model, individual participants will 
be specified as a random effect, accounting for the within subject covariance structure. The 
effect of group and time will be specified as fixed effects using a joint variable of 
intervention and time. Here, baseline levels are pooled over the two study groups assuming 
that any baseline differences are due to chance; this also controls for any baseline differences 
in the outcome variable. The between group difference at tree months will be adjusted for the 
two variables used for stratification in the randomisation (i.e., country and care provider). 
Further adjustment for baseline levels of potentially important prognostic factors, such as age, 
sex, socioeconomic status, pain duration, and pain intensity will also be conducted. We will 
also use GEE analyses to estimate an odds ratio (with 95% CI) for a two-point change in 
RMDQ between the groups taking into account the repeated observations. This analysis will 
be adjusted for the same factors as those included in the linear mixed model. 
To reduce the risk of biased interpretation of results for the primary outcome we will 
use the following procedure: Two interpretations will be drafted based on the results from the 
main analyses, with interventions groups arbitrarily labelled as A and B. One interpretation 
assumes that A is the SELFBACK DSS in addition to usual care and B is usual care, the other 
interpretation assumes that A is the usual care and B is the selfBACK DSS in addition to 
usual care. After agreeing on both interpretations, the randomisation code is broken, and the 
correct interpretation will be used. 
In addition to the intention to treat analyses, we will conduct per protocol analyses 
using information on adherence to the trial as described in chapter 4.2 above.  
All secondary outcomes will be analysed using a similar approach; for continuous (or 
approximately continuous) we will use linear mixed models to estimate mean differences 
between groups, and for ordinal or binary variables we will use logistic GEE analyses to 
estimate odds ratios. Pre-specified cut-offs for ordinal and binary variables are described in 
6.1 above. For analyses of mean differences, the distribution of each outcome variable will be 
assessed to inform possible transformation or initiate alternative analytical procedures (e.g. 
non-parametric analyses). The precision of all estimated effects will be assessed by a 95% CI. 
Possible modifiers of the effect of intervention on the primary outcome will be 
assessed in supplementary analyses stratified by sex, age groups, socioeconomic status and 




assess departure from additive effects (i.e., including a product term of group and modifier in 
the regression model). 
 
6.3 Missing data 
 
Any missing values are inherently accounted for in the mixed model approach, but multiple 
imputation methods and complete case analysis will be applied in sensitivity analyses. 
Multiple imputation will include factors that predict missingness of a specific factor, as well 
as all factors that are included in the main model (outcome, intervention, or adjustment 
variables). The number of imputed datasets will be guided by the number of missing 
observations for each variable, but we aim at using a minimum of 10 imputed datasets for 
each variable. 
 
6.4 Additional analyses 
 
Additional analyses include per protocol analyses, analyses of secondary outcomes, analyses 
stratified by possible effect modifiers, analyses using multiple imputation of missing data and 




As stated above, no harms are expected, and thus we do not plan any specific analyses for 
this. If any study related harms should occur, these will be described and reported.  
 
6.6 Statistical software 
 
All analyses related to the primary outcome will be conducted using Stata, whereas analyses 
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